Our people

Mary-Jane joined Buchanan in 2003 from the FTSE 250 biotechnology company PowderJect Pharmaceuticals Plc where she was a key member of the Company's corporate communications and investor relations team. A graduate of Sheffield University, Mary-Jane joined PowderJect initially as a research scientist before moving into communications. She has experience of in-house and agency PR and, as a specialist in life sciences, she has advised on a wide range of financial communications including fundraisings, M&A, crisis management and IPOs - both in the UK and internationally.

Email: mary-jane.johnson@buchanan.uk.com